News & Updates
Showing Oncology articles
Showing
Show Multimedia Only

Statins reduce hepatocellular carcinoma risk in cirrhotic patients
17 Nov 2021
The risk of hepatocellular carcinoma (HCC) among patients with nonalcoholic steatohepatitis (NASH) and bridging fibrosis is low, reveals a recent study. In addition, dose-dependent statin can substantially lower the risk of HCC in patients with NASH cirrhosis.
17 Nov 2021

